Drug Shortage Report for TEVA-MIRTAZAPINE
| Report ID | 206407 |
| Drug Identification Number | 02259354 |
| Brand name | TEVA-MIRTAZAPINE |
| Common or Proper name | MIRTAZAPINE 30MG TABS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MIRTAZAPINE |
| Strength(s) | 30MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | pp 30 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-10-04 |
| Estimated end date | 2024-06-10 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-11-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-11-09 | French | Compare |
| v5 | 2023-11-09 | English | Compare |
| v4 | 2023-11-03 | French | Compare |
| v3 | 2023-11-03 | English | Compare |
| v2 | 2023-10-05 | French | Compare |
| v1 | 2023-10-05 | English | Compare |
Showing 1 to 6 of 6